How Often Do You Increase the Dose of Wegovy — and What Drives That Decision?

Why the four-week spacing exists

The titration schedule built into Wegovy's licensed dosing structure serves one purpose: giving your gut time to adapt. Semaglutide slows gastric emptying and acts on GLP-1 receptors involved in appetite signalling, and those effects can produce nausea, loose stools or fatigue when the dose is new. Four weeks gives most people enough time to reach a steady state before the next increase.

The NHS medicines information for semaglutide sets out this graduated approach clearly, and it is the framework every UK prescriber follows. Most people move through the five steps and reach 2.4 mg within about five months, but that figure assumes no pauses, which is rarely the realistic picture.

If you want to understand the full dose range and what each level is trying to achieve, the Wegovy doses guide covers each step in detail. The spacing is clinical logic, not arbitrary; rushing it tends to mean worse nausea and a higher chance of stalling altogether.

When a prescriber might slow down (or hold) a dose increase

This is where the decision-led framing really matters. Tolerability is the gating factor. If you are still experiencing daily nausea or significant vomiting heading into week four, moving to the next dose would almost certainly make things worse. Staying at the current level for an extra four weeks (sometimes called an extended titration) is a well-recognised clinical approach and is not a sign that something has gone wrong.

There are other reasons a prescriber might hold a step: a recent illness, significant gastrointestinal upset, a period of unusually poor eating, or simply a patient's own preference to stay comfortable before moving on. If you are wondering how often you should increase your Wegovy dose and what factors influence that timing, the guidance on how often to increase Wegovy explores these scenarios in more depth alongside guidance on how often to increase Wegovy.

What you should not do is increase the dose yourself, or delay it indefinitely based on gut feeling alone. The conversation belongs between you and your prescriber, who can look at your full picture, not just the dose.

The side-effect profile around each increase

The pattern most people notice is that side effects flare mildly in the days after a new dose, then settle over one to two weeks. Nausea is the most commonly reported symptom; constipation, indigestion and fatigue also feature. For most people these are manageable, particularly if they have already been on the previous dose for a full four weeks.

What is worth knowing is that the side-effect profile at Wegovy's highest doses can differ from what you experienced at 0.25 mg or 0.5 mg. Gastrointestinal symptoms tend to be more pronounced at 1.7 mg and 2.4 mg. That is normal, it does not mean you must push through anything intolerable, and it is another reason clinical oversight matters at every step rather than just at the start.

Eating a smaller, lower-fat meal before your weekly injection, staying well hydrated, and spacing other oral medicines away from your dose can all help. Your prescriber and the Patient Information Leaflet are the right sources for personalised advice here.

The 7.2 mg dose, and what it changes about this decision

In April 2026, the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, extending the titration ladder further for adults with a BMI of 30 or above. Trials at this dose reported an average weight reduction of around 20.7% over 72 weeks, approaching the results seen with the highest tirzepatide doses in the SURMOUNT-5 head-to-head trial.

The starting point remains 0.25 mg; patients already established on 2.4 mg weekly do not restart from scratch, but the move to 7.2 mg still requires a clinical assessment. You can read the full background on the Wegovy treatment overview, which covers both the injection and the newer oral tablet approved in June 2026.

If you are weighing up what dose trajectory suits you, or whether Wegovy is the right treatment at all, the weight-loss treatment options page gives a broader picture across licensed medicines. And for context on what treatment costs across providers, this Wegovy price comparison sets out the landscape honestly, worth reading before you commit anywhere.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not triaged by software. If you order before midday on a weekday, your consultation is reviewed the same day, your pen then goes out the same afternoon if you are clinically suitable, with free next-working-day tracked delivery via DPD. The prescriber looks at your dose history, any current side effects, and whether moving up makes sense for you specifically. That review happens every time, not just at the start.

If you have specific questions about your current titration or are unsure whether to progress, our aftercare team is available seven days a week. Ready to get started? Start your free consultation and our prescribers will take it from there.